These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 31814295)
21. Clinicopathologic features and prognoses of different histologic types of triple-negative breast cancer: A large population-based analysis. Zhao S; Ma D; Xiao Y; Jiang YZ; Shao ZM Eur J Surg Oncol; 2018 Apr; 44(4):420-428. PubMed ID: 29429597 [TBL] [Abstract][Full Text] [Related]
22. Histologic subtyping affecting outcome of triple negative breast cancer: a large Sardinian population-based analysis. Sanges F; Floris M; Cossu-Rocca P; Muroni MR; Pira G; Urru SAM; Barrocu R; Gallus S; Bosetti C; D'Incalci M; Manca A; Uras MG; Medda R; Sollai E; Murgia A; Palmas D; Atzori F; Zinellu A; Cambosu F; Moi T; Ghiani M; Marras V; Santona MC; Canu L; Valle E; Sarobba MG; Onnis D; Asunis A; Cossu S; OrrĂ¹ S; De Miglio MR BMC Cancer; 2020 Jun; 20(1):491. PubMed ID: 32487046 [TBL] [Abstract][Full Text] [Related]
23. Population-based validation of the National Cancer Comprehensive Network recommendations for breast cancer staging. Abdel-Rahman O Breast Cancer Res Treat; 2018 Nov; 172(1):231-238. PubMed ID: 30022329 [TBL] [Abstract][Full Text] [Related]
24. Incidence and patterns of distant metastases for patients with early-stage breast cancer after breast conservation treatment. Berman AT; Thukral AD; Hwang WT; Solin LJ; Vapiwala N Clin Breast Cancer; 2013 Apr; 13(2):88-94. PubMed ID: 23218473 [TBL] [Abstract][Full Text] [Related]
25. How do organ-specific metastases affect prognosis and surgical treatment for patients with metastatic upper tract urothelial carcinoma: first evidence from population based data. Dong F; Fu H; Shi X; Shen Y; Xu T; Gao F; Wang X; Zhong S; Ding Q; Shen Z; Chen S Clin Exp Metastasis; 2017 Dec; 34(8):467-477. PubMed ID: 29500709 [TBL] [Abstract][Full Text] [Related]
26. De novo metastasis in breast cancer: occurrence and overall survival stratified by molecular subtype. Press DJ; Miller ME; Liederbach E; Yao K; Huo D Clin Exp Metastasis; 2017 Dec; 34(8):457-465. PubMed ID: 29288366 [TBL] [Abstract][Full Text] [Related]
27. Distant metastasis in triple-negative breast cancer. Tseng LM; Hsu NC; Chen SC; Lu YS; Lin CH; Chang DY; Li H; Lin YC; Chang HK; Chao TC; Ouyang F; Hou MF Neoplasma; 2013; 60(3):290-4. PubMed ID: 23373998 [TBL] [Abstract][Full Text] [Related]
28. Comparison of invasive micropapillary and triple negative invasive ductal carcinoma of the breast. Chen HL; Ding A Breast; 2015 Dec; 24(6):723-31. PubMed ID: 26392199 [TBL] [Abstract][Full Text] [Related]
29. T1-2N0M0 Triple-Negative Breast Cancer Treated With Breast-Conserving Therapy Has Better Survival Compared to Mastectomy: A SEER Population-Based Retrospective Analysis. Li H; Chen Y; Wang X; Tang L; Guan X Clin Breast Cancer; 2019 Dec; 19(6):e669-e682. PubMed ID: 31375327 [TBL] [Abstract][Full Text] [Related]
30. [Treatment outcomes and clinicopathologic characteristics of advanced triple-negative breast cancer patients]. Zhang P; Xu BH; Ma F; Li Q; Yuan P; Wang JY; Zhang P Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):381-4. PubMed ID: 21875471 [TBL] [Abstract][Full Text] [Related]
31. Triple-negative breast cancer has worse overall survival and cause-specific survival than non-triple-negative breast cancer. Li X; Yang J; Peng L; Sahin AA; Huo L; Ward KC; O'Regan R; Torres MA; Meisel JL Breast Cancer Res Treat; 2017 Jan; 161(2):279-287. PubMed ID: 27888421 [TBL] [Abstract][Full Text] [Related]
32. Frequency and clinicopathological features of metastasis to liver, lung, bone, and brain from gastric cancer: A SEER-based study. Qiu MZ; Shi SM; Chen ZH; Yu HE; Sheng H; Jin Y; Wang DS; Wang FH; Li YH; Xie D; Zhou ZW; Yang DJ; Xu RH Cancer Med; 2018 Aug; 7(8):3662-3672. PubMed ID: 29984918 [TBL] [Abstract][Full Text] [Related]
33. Incidence and prognosis of non-metastatic triple negative breast cancer (TNBC) among different races in Southeast Asia. Alcantara VS; Lim GH; Lim SH; Sultana R; Lee JA J Surg Oncol; 2017 Apr; 115(5):523-537. PubMed ID: 28168712 [TBL] [Abstract][Full Text] [Related]
34. Association between androgen receptor status and prognosis in triple negative breast cancer. Sunar V; T Dogan H; Sarici F; Ates O; Akin S; Baspinar B; Aksoy S; Altundag K J BUON; 2018; 23(5):1325-1330. PubMed ID: 30570854 [TBL] [Abstract][Full Text] [Related]
35. Prognostic factors and survival according to tumour subtype in women presenting with breast cancer bone metastases at initial diagnosis: a SEER-based study. Li X; Zhang X; Liu J; Shen Y BMC Cancer; 2020 Nov; 20(1):1102. PubMed ID: 33187507 [TBL] [Abstract][Full Text] [Related]
36. Prognostic Significance of Sites of Visceral Metastatic Disease in Prostate Cancer: A Population-based Study of 12,180 Patients. Budnik J; Suri J; Bates JE; Bylund KC; Milano MT Clin Genitourin Cancer; 2019 Aug; 17(4):260-267. PubMed ID: 31101579 [TBL] [Abstract][Full Text] [Related]
37. High prevalence and predominance of BRCA1 germline mutations in Pakistani triple-negative breast cancer patients. Rashid MU; Muhammad N; Bajwa S; Faisal S; Tahseen M; Bermejo JL; Amin A; Loya A; Hamann U BMC Cancer; 2016 Aug; 16(1):673. PubMed ID: 27553291 [TBL] [Abstract][Full Text] [Related]
38. Risk factors of distant metastasis after surgery among different breast cancer subtypes: a hospital-based study in Indonesia. Anwar SL; Avanti WS; Nugroho AC; Choridah L; Dwianingsih EK; Harahap WA; Aryandono T; Wulaningsih W World J Surg Oncol; 2020 May; 18(1):117. PubMed ID: 32473643 [TBL] [Abstract][Full Text] [Related]
39. [Clinical features and prognosis of patients with first-episode liver metastasis of different molecular subtypes of breast cancer]. Wu SY; Tan Y; Guan YS Zhonghua Gan Zang Bing Za Zhi; 2016 Jun; 24(6):422-8. PubMed ID: 27465945 [TBL] [Abstract][Full Text] [Related]